Incidence trends of cervical cancer in Puerto Rico, 1987-2004

Puerto Rico Health Sciences Journal

Volumn 29, Issue 4, 2010, Pages 364-371

  Pérez Irizarry, Javier ^a   Nazario Delgado, Cruz M ^a   de la Torre, Taina ^a   Ortiz Ortiz, Karen J ^a   Torres Cintrón, Mariela ^a   Figueroa Vallés, Nayda R ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Adenocarcinoma; Cervical cancer; Incidence trends; Squamous cell carcinoma

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; PUERTO RICO; SQUAMOUS CELL CARCINOMA; TIME; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PUERTO RICO; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78649425883     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 Mar-Apr;55:74-108.
2. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide [computer program]. Version 2.0. Lyon France: IARC Press 2004; 2010.
3. Martinez I. Changes of morbidity and mortality from cancer of the cervix uteri in Puerto Rico. Bol Asoc Med P R 1984;76:100-106.
4. Departamento de Salud de Puerto Rico. Informe Cáncer de Puerto Rico 1991. Registro Central de Cáncer de Puerto Rico; 1993.
5. Grandes G. Impacto del Programa de Detección Precoz sobre la inciden-cia y mortalidad por cáncer invasivo escamoso de cerviz en Puerto Rico, 1969-1987 [master's thesis]. San Juan, PR; University of Puerto Rico, Medical Sciences Campus; 1990.
6. Karim-Kos HE, de Vries E, et. al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345-1389.
7. Surveillance, Epidemiology, and EndResults (SEER) Program(www.seer.cancer.gov). SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
8. Ortiz AP, Soto-Salgado M, Calo WA, et al. Incidence and mortality rates of selected infection-related cancers in Puerto Rico and the United States. Infect Agent Cancer 2010;5:10.
9. Ronco G, Pilutti S, Patriarca S, et al. Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98. Br J Cancer 2005;93:376-378.
10. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-686.
11. Comber H, Gavin A. Recent trends in cervical cancer mortality in Britain and Ireland: the case for population-based cervical cancer screening. Br J Cancer 2004;91:1902-1904.
12. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318:904-908.
13. IARC. Cervix cancer screening. IARC Handbooks of Cancer Prevention. Lyon, France: IARC Press; 2005.
14. López de Munaim J. Epidemiologa descriptiva del cáncer invasivo de cervix de Puerto Rico, 1963-1987 [master's thesis]. San Juan, PR; University of Puerto Rico, Medical Sciences Campus; 1990.
15. Drain PK, Holmes KK, Hughes JP, Koutsky LA. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002;100:199-205.
16. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intra-epithelial neoplasia. J Natl Cancer Inst 1993;85:958-964.
17. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavi-rus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
18. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
19. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillo-mavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
20. Castellsague X, Diaz M, de Sanjose S., et al. Worldwide human papilloma-virus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006 Mar 1;98:303-315.
21. Appleby P, Beral V, Berrington de Gonzalez A., et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006 Mar 15;118:1481-1495.
22. Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003 Apr 5;361:1159-1167.
23. Appleby P, Beral V, Berrington de Gonzalez A, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007;370: 1609-1621.
24. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;20-28.
25. Berrington de Gonzalez A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analy-sis. Br J Cancer 2004;90:1787-1791.
26. Lacey J V, Jr., Swanson CA, Brinton LA, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003;98:814-821.
27. Lacey J V, Jr., Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999;8:1079-1085.
28. Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study. Cancer Causes Control 2003;14:805-814.
29. Lacey JV, Jr., Brinton LA, Barnes WA, et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000;77:149-154.
30. Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004;111:431-439.
31. Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachoma-tis and risk for development of cervical squamous cell carcinoma. JAMA 2001;285:47-51.
32. Madeleine MM, Anttila T, Schwartz SM, et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 2007;120:650-655.
33. Koskela P, Anttila T, Bjorge T, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000;85:35-39.
34. Lech MM, Ostrowska L. Risk of cancer development in relation to oral contraception. Eur J Contracept Reprod Health Care 2006;11:162-168.
35. dos Santos Silva I, Beral V. Socioeconomic differences in reproductive behaviour. IARC Sci Publ 1997;285-308.
36. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ 1997;65-176.
37. Winkelstein W, Jr. Smoking and cervical cancer--current status: a review. Am J Epidemiol 1990 Jun;131:945-957.
38. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003 Sep-Oct;9:348-359.
39. Puerto Rico Central Cancer Registry (PRCCR). Incidence Case File--Feb 2010. Comprehensive Cancer Center of University of Puerto Rico, 2010.
40. Fritz A, Jack A, Percy C, et al. International classification of diseases for oncology, 3rd ed. Geneva: World Health Organization; 2000.
41. SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.5.2. [computer program]. Version 6.5.2 2010.
42. Junta de Planificación, Programa de Planificación Económica y Social, Oficina del Censo. Población Estimada, Puerto Rico; 2000.
43. Joinpoint Regression Program [computer program]. Version 3.4.2. Bethesda, Md: National Cancer Institute, Division of Cancer Control and Population Sciences, Statistical Research and Applications Branch, 2002; 2010.
44. Bulk S, Visser O, Rozendaal L, et al. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005;113: 1005-1009.
45. Liu S, Semenciw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 2001 Apr 17;164:1151-1152.
46. Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003 Oct;102:765-773.
47. Bray F, Carstensen B, Moller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005 Sep;14:2191-2199.
48. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of ad-enocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. Gynecol Oncol 2000 Aug;78:97-105.
49. Vazquez-Calzada J. La Población de Puerto Rico y su Trayectoria Históri-ca [The Population of Puerto Rico and its historic evolution]. Rio Pie-dras, PR: Raga Offset Printing Service, 1988.
50. Pan American Health Organization: Special Program for Health Analysis Based on: World Population Prospects: the 1998 Revision United Nations. 1998.
51. Behavioral Risk Factor Surveillance System Survey Data [computer program]. Atlanta, Georgia: U.S: Department of Health and Human Services, Centers for Disease Control and Prevention; 1996-2004.
52. Rigau-Perez JG. Health in Puerto Rico in the 20th century [in Spansh]. P R Health Sci J 2000 Dec;19:357-368.
53. Negociado del Censo Federal. Censo de Población y Vivienda de Puerto Rico: 1990 y 2000); Año 1990, Compendio de Datos 3a y Año 2000, Compendio de Datos3) y Junta de Planificación, Programa de Planifi-cación Económica y Social, Oficina del Censo; 2000.
54. Moodley J. Combined oral contraceptives and cervical cancer. Curr Opin Obstet Gynecol 2004 Feb;16:27-29.
55. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002;359: 1085-1092.
56. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24 Suppl 3:S3-1-S310.
57. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papil-lomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002 Mar 30;359:1093-1101.
58. Dávila AL, Ramos G, Mattei H. Encuesta de Salud Reproductiva: Puerto Rico, 1995-1996. Resumen de los Hallazgos. [Reproductive Health Survey: Puerto Rico, 1995-1996:Summary Report]. San Juan, Puerto Rico: Escuela Graduada de Salud Pública; 1998.
59. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papil-lomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987 Aug 15;40:198-201.
60. Puerto Rico Department of Health,Axillary Secretariat for Planning and Development, Division of Statistical Analysis. Informe Anual de Estadís-ticas de Puerto Rico, 2003: Table 11-Specific Fertility Rates. San Juan, Puerto Rico.
61. Ortiz AP, Perez J, Otero-Dominguez Y, et al. Endometrial cancer in Puerto Rico: incidence, mortality and survival (1992-2003). BMC Cancer 2010;10:31.
62. Nazario CM, Figueroa-Valles N, Rosario RV. Breast cancer patterns and lifetime risk of developing breast cancer among Puerto Rican females. P R Health Sci J 2000 Mar;19:7-13.
63. Ortiz-Ortiz KJ, Figueroa-Vallés NR, Pérez-Irizarry J, et al. Patrones de in-cidencia y Mortalidad de Cáncer de Mama en Puerto Rico. Revista Puer-torriqueña de Medicina y Salud Pública 2009;15:19-27.
64. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papil-lomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-236.
65. Smith JS, Herrero R, Bosetti C, et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002 Nov 6;94:1604-1613.
66. Departamento de Salud de Puerto Rico. Programa de Prevención de ETS/VIH/SIDA. 2005.
67. CDC. HIV/AIDS among Hispanics. National Center for HIV, STD, and TB Prevention, Divisions of HIV/AIDS prevention.11-16-2004, 2-7. 2005.
68. Maiman M, Fruchter RG, Clark M, et al. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1997 Jan;89:76-80.
69. Ramirez-Marrero FA, Smith E, De La Torre-Feliciano T, et al. Risk of cancer among Hispanics with AIDS compared with the general population in Puerto Rico: 1987- 2003. P R Health Sci J 2010;3:29.
70. Mosher WD, Chandra A, Jones J. Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data 2005 Sep 15;1-55.
71. Finer LB, Darroch JE, Singh S. Sexual partnership patterns as a behavioral risk factor for sexually transmitted diseases. Fam Plann Perspect 1999 Sep-Oct;31:228-236.
72. National Center for Chronic Disease Prevention and Health Promotion, Division of Adolescent and School Health. Youth Risk Behavior System Surveillance Data. Atlanta, Georgia: U.S: Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.
73. Kalir T, Simsir A, Demopoulos HB, Demopoulos RI. Obstacles to the early detection of endocervical adenocarcinoma. Int J Gynecol Pathol 2005 Oct;24:399-403.
74. Zappa M, Visioli CB, Ciatto S, et al. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer 2004;90:1784-1786.
75. Wu X, Groves FD, McLaughlin CC, et al. Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control 2005 Apr;16:309-320.
76. Ortiz AP, Hebl S, Serrano R, et al. Factors associated with cervical cancer screening in Puerto Rico. Prev Chronic Dis 2010 May;7:A58.
77. National Program of Cancer Registries: Technical Assistance and Audit Puerto Rico Central Cancer Registry, Case Completeness and Data Quality Audit. Atlanta, Georgia: Centers for Disease Control and Prevention; 2003.
78. Luoto R, Raitanen J, Pukkala E, Anttila A. Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010. Br J Cancer 2004 May 4;90:1756-1759.